help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LASSUS, P.
Right arrow Articles by ANDERSSON, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LASSUS, P.
Right arrow Articles by ANDERSSON, S.

Am. J. Respir. Crit. Care Med., Volume 159, Number 5, May 1999, 1429-1433

Vascular Endothelial Growth Factor in Human Preterm Lung

PATRIK LASSUS, ARI RISTIMÄKI, OLAVI YLIKORKALA, LASSE VIINIKKA, and STURE ANDERSSON

The Hospital for Children and Adolescents, Department of Obstetrics and Gynecology, and Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland

Endothelial cell damage is characteristic for respiratory distress syndrome and development of chronic lung disease. Vascular endothelial growth factor (VEGF) is an endothelial mitogen that takes part in the growth and repair of vascular endothelial cells. We measured VEGF in 189 tracheal aspirate samples (TAF), and in 24 plasma samples from 44 intubated preterm infants (gestational age, 27.3 ± 2.0 wk; birth weight, 962 ± 319 g) during their first postnatal week. VEGF in TAF increased from 25 ± 12 pg/ml (mean ± SEM) on Day 1 to 526 ± 120 pg/ml on Day 7 (mean concentrations, 106 ± 25 pg/ml on Days 1 to 3 and 342 ± 36 pg/ml on Days 4 to 7). In plasma, mean concentration of VEGF during the first week was 48 ± 6 pg/ml, with no increase observed. In TAF, higher VEGF was found in patients born to mothers with premature rupture of the membranes, or chorionamnionitis, whereas preeclampsia of the mother was associated with lower VEGF (all p < 0.05). In TAF, no correlations existed between VEGF and gestational age or birth weight, but a correlation existed between lecithin/sphengomyelin ratio and VEGF (p < 0.05). During Days 4 to 7 patients developing bronchopulmonary dysplasia (BPD) had lower VEGF in TAF than did those surviving without BPD (235 ± 31 versus 383 ± 50; p < 0.05). VEGF increased rapidly in the lungs of the preterm infant during the first days of life. VEGF may be indicative of pulmonary maturity and may participate in pulmonary repair after acute lung injury.




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. A. Nemec and A. Barchowsky
Signal Transducer and Activator of Transcription 1 (STAT1) is Essential for Chromium Silencing of Gene Induction in Human Airway Epithelial Cells
Toxicol. Sci., July 1, 2009; 110(1): 212 - 223.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Hasan, K. D. Beharry, A. M. Valencia, A. Strauss, and H. D. Modanlou
Soluble Vascular Endothelial Growth Factor Receptor 1 in Tracheal Aspirate Fluid of Preterm Neonates at Birth May Be Predictive of Bronchopulmonary Dysplasia/Chronic Lung Disease
Pediatrics, June 1, 2009; 123(6): 1541 - 1547.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Janer, S. Andersson, E. Kajantie, and P. Lassus
Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants
Pediatrics, April 1, 2009; 123(4): 1142 - 1146.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. Tschirch, B. Weber, P. Koehne, F. Guthmann, A. von Gise, R. R. Wauer, and M. Rudiger
Vascular Endothelial Growth Factor as Marker for Tissue Hypoxia and Transfusion Need in Anemic Infants: A Prospective Clinical Study
Pediatrics, March 1, 2009; 123(3): 784 - 790.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
C L Bose, C E L Dammann, and M M Laughon
Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F455 - F461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
V. Bhandari, R. Choo-Wing, C. G. Lee, K. Yusuf, J. H. Nedrelow, N. Ambalavanan, H. Malkus, R. J. Homer, and J. A. Elias
Developmental Regulation of NO-Mediated VEGF-Induced Effects in the Lung
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 420 - 430.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Janer, S. Andersson, C. Haglund, R. Karikoski, and P. Lassus
Placental Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Human Lung Development
Pediatrics, August 1, 2008; 122(2): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
C Pieh, H Agostini, C Buschbeck, M Kruger, J Schulte-Monting, U Zirrgiebel, J Drevs, and W A Lagreze
VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity
Br J Ophthalmol, May 1, 2008; 92(5): 689 - 693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Thebaud and S. H. Abman
Bronchopulmonary Dysplasia: Where Have All the Vessels Gone? Roles of Angiogenic Growth Factors in Chronic Lung Disease
Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 978 - 985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2006
Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 532 - 540.
[Full Text] [PDF]


Home page
PediatricsHome page
J. Janer, S. Andersson, C. Haglund, and P. Lassus
Pulmonary Endostatin Perinatally and in Lung Injury of the Newborn Infant
Pediatrics, January 1, 2007; 119(1): e241 - e246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Janer, P. Lassus, C. Haglund, K. Paavonen, K. Alitalo, and S. Andersson
Pulmonary Vascular Endothelial Growth Factor-C in Development and Lung Injury in Preterm Infants
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 326 - 330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. D. Le Cras, R. E. Spitzmiller, K. H. Albertine, J. M. Greenberg, J. A. Whitsett, and A. L. Akeson
VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L134 - L142.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. Lambert, R. Michel, G.-M. Mazmanian, E. M. Dulmet, A. Capderou, P. Herve, C. Planche, and A. Serraf
Induction of pulmonary angiogenesis by adenoviral-mediated gene transfer of vascular endothelial growth factor
Ann. Thorac. Surg., February 1, 2004; 77(2): 458 - 463.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. D. Le Cras, W. D. Hardie, K. Fagan, J. A. Whitsett, and T. R. Korfhagen
Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-{alpha}
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1046 - L1054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Vento, P. G. Matassa, E. Capoluongo, L. Tortorolo, C. Romagnoli, F. Ameglio, P. Lassus, and S. Andersson
Glucocorticoids in Preterm Infants and Discrepancies of Vascular Endothelial Growth Factor
Am. J. Respir. Crit. Care Med., August 15, 2003; 168(4): 501 - 502.
[Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Mata-Greenwood, B. Meyrick, S. J. Soifer, J. R. Fineman, and S. M. Black
Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L222 - L231.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. Lassus, I. Nupponen, A. Kari, M. Pohjavuori, and S. Andersson
Early Postnatal Dexamethasone Decreases Hepatocyte Growth Factor in Tracheal Aspirate Fluid From Premature Infants
Pediatrics, October 1, 2002; 110(4): 768 - 771.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. D. Le Cras, N. E. Markham, R. M. Tuder, N. F. Voelkel, and S. H. Abman
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L555 - L562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. J. BHATT, G. S. PRYHUBER, H. HUYCK, R. H. WATKINS, L. A. METLAY, and W. M. MANISCALCO
Disrupted Pulmonary Vasculature and Decreased Vascular Endothelial Growth Factor, Flt-1, and TIE-2 in Human Infants Dying with Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1971 - 1980.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. LASSUS, M. TURANLAHTI, P. HEIKKILA, L. C. ANDERSSON, I. NUPPONEN, A. SARNESTO, and S. ANDERSSON
Pulmonary Vascular Endothelial Growth Factor and Flt-1 in Fetuses, in Acute and Chronic Lung Disease, and in Persistent Pulmonary Hypertension of the Newborn
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1981 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.E. Currie, J.R. Vyas, J. MacDonald, D. Field, and S. Kotecha
Epidermal growth factor in the lungs of infants developing chronic lung disease
Eur. Respir. J., November 1, 2001; 18(5): 796 - 800.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. C. Meyer, A. L. Cardoni, Z. Xiang, R. D. Cornwell, and R. B. Love
Vascular Endothelial Growth Factor in Human Lung Transplantation
Chest, January 1, 2001; 119(1): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Boussat, S. Eddahibi, A. Coste, V. Fataccioli, M. Gouge, B. Housset, S. Adnot, and B. Maitre
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L371 - L378.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. L. Starnes, B. W. Duncan, J. M. Kneebone, G. L. Rosenthal, T. K. Jones, R. G. Grifka, F. Cecchin, D. J. Owens, C. Fearneyhough, and F. M. Lupinetti
VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN CHILDREN WITH CYANOTIC CONGENITAL HEART DISEASE
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. M. Maniscalco, R. H. Watkins, G. S. Pryhuber, A. Bhatt, C. Shea, and H. Huyck
Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L811 - L823.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society
  ATS Quiz on Sleep Study Tracings